psychedelics webinar recap

Psychedelics Webinar Recap

Last week, we presented a psychedelics webinar entitled “How to Protect Your Psychedelics Business.” The panelists were Paul Coble from our Phoenix office), me (Griffen Thorne from our Los Angeles office), and Graham Pechenik of Calyx Law in San Francisco. In the webinar, we presented on business law and intellectual property issues that will affect

proposed rules

Oregon Proposed Psilocybin Rules: Tracking, Advertising, Prohibited Conduct

This is the sixth and final installment in my write-up of the proposed Oregon psilocybin program rules. This post will cover product transportation and tracking, advertising, prohibited conduct, and penalties. I’ll skip waste management. As with earlier installments in this series (linked below), this post will highlight key areas and skip or skim less prominent

psilocybin facilitator

Oregon Proposed Psilocybin Rules: Facilitators, Sessions and Dosing

Welcome to the penultimate installment in my write-up of the proposed Oregon psilocybin program rules. This post focuses on facilitators and related client matters. It does not canvass the already-adopted rules related to facilitator licensing, which we covered back in April. As with earlier installments in this series (see links below), this post will highlight

oregon psilocybin draft rules

Oregon Proposed Psilocybin Rules: Highlights

The Oregon Health Authority (OHA) released the rest of its draft psilocybin rules as predicted a few weeks back. We’ve had a minute to look at them. This post and the next few will cover some of the high points. In general, OHA did a good job implementing the Oregon Psilocybin Advisory Board’s (“Board”) recommendations

utah ketamine

Utah Ketamine Clinics Face New Patient Monitoring Law

Earlier this year, Utah passed a law that will directly impact ketamine clinics. The new law is entitled “Anesthesia and sedation requirements – Unprofessional conduct – Whistleblower protection.” Ut. St. § 58-1-510. The new law is effective as of May 4, 2022, but the implementing regulations have been passed or implemented yet. We believe that

oregon psilocybin advisory board

Oregon Psilocybin Advisory Board: June 22, 2022 Meeting

The Oregon Psilocybin Advisory Board (OPAB) was established by Measure 109 and is responsible for making recommendations to the Oregon Health Authority (OHA) for psilocybin services in Oregon. OPAB has met monthly since March of 2021, and the last monthly meeting was set for June 22, 2022. After that, OPAB will meet every two months. In a

oregon psilocybin training

Oregon Psilocybin Draft Rules: Training

On Friday, April 1, 2022 the Oregon Health Authority (OHA) released revised proposed Oregon Administrative Rules (OARs) for psilocybin services. These rules focus on psilocybin products, testing, and training programs. There will be public hearings on these rules on April 18 and April 21, 2021. In part one, we covered the rules related to psilocybin

oregon psilocybin business

Oregon Psilocybin: Banking

Welcome to the second installment in this series surveying business and regulatory issues for Oregon psilocybin program players. In part one, I covered the general process and schedule of Oregon Health Authority (OHA) rulemaking, by and through the Oregon Psilocybin Advisory Board. I also covered residency requirements, further restrictions on ownership, and taxation issues. In

due diligence ketamine

Ketamine Due Diligence: What Any Buyer Should Know

We have worked on several ketamine acquisitions, and one of the most important aspects of any deal is due diligence. Shortly after term sheets or letters of intent are executed, most buyers send out a due diligence request list to the seller. This post will focus on the healthcare regulatory issues a buyer will want